Watson Pharma (WPI) to Reorganize Corona, CA, Facility; Sees Charges
Tweet Send to a FriendGet Alerts WPI Hot Sheet
Price: $85.73 --0%
EPS Growth %: +23.9%
Financial Fact:
Net income: -103.5M
Today's EPS Names:
TARO, SENEA, UQM, More
EPS Growth %: +23.9%
Financial Fact:
Net income: -103.5M
Today's EPS Names:
TARO, SENEA, UQM, More
Trade WPI Now!
As part of its ongoing efforts to improve the efficiency of its global supply chain, on January 3, 2013, Watson Pharmaceuticals, Inc. (NYSE: WPI) announced plans to restructure operations at its Corona, California facility. In connection with the restructuring, manufacturing and related support functions at the site will be reduced and activities at the facility going forward will be focused only on the production of oral contraceptives. Manufacturing and packaging of other products will be transferred to other sites within the Company’s global supply chain. While the timing of the completion of the restructuring will depend on a number of factors, we anticipate that the restructuring will be complete by the end of 2014.
The Company expects to incur pre-tax future cash expenditures associated with the planned closures, including the following:
The Company also expects to incur non-cash accelerated depreciation charges as part of the restructuring. At this time the Company is unable to estimate the accelerated depreciation charges to be incurred through the estimated completion date.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The Company expects to incur pre-tax future cash expenditures associated with the planned closures, including the following:
- severance, retention, relocation and other employee related costs of approximately $10 to $12 million; and
- product transfer costs of approximately $3 to $4 million.
The Company also expects to incur non-cash accelerated depreciation charges as part of the restructuring. At this time the Company is unable to estimate the accelerated depreciation charges to be incurred through the estimated completion date.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- salesforce.com, Inc. (CRM) Reports In-Line Q1 EPS; Issues In-Line Q2, FY14 Outlook
- Pandora Media (P) Reports In-Line Q1 EPS, Revenue & Guidance Beat
- Ross Stores, Inc. (ROST) Reports In-Line Q1 EPS, Raises Guidance
Create E-mail Alert Related Categories
Corporate News, Guidance
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
